Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -67.62% is 68% below its 5-year average of -40.14%, near the low end of its 5-year range (-75.38%–-15.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 21.98% below its 12-month average of -55.43%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -67.62%.
RETURN ON INVESTED CAPITAL (ROIC)
-67.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-55.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-49.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-40.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-46.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-21.98%
CURRENT VS 3Y AVG
-35.81%
CURRENT VS 5Y AVG
-68.44%
CURRENT VS 10Y AVG
-43.92%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-89.69%
vs the sector median at left
Citius Pharmaceuticals, Inc.
Market Cap
$13.23M
Return on Invested Capital (ROIC)
-67.62%
TTM Avg
-55.43%
3Y Avg
-49.79%
5Y Avg
-40.14%
Market Cap
$13.11M
Return on Invested Capital (ROIC)
-91.74%
TTM Avg
-119.31%
3Y Avg
-112.64%
5Y Avg
-88.90%
Market Cap
$13.08M
Return on Invested Capital (ROIC)
-889.92%
TTM Avg
-97.42%
3Y Avg
-82.73%
5Y Avg
-70.79%
Market Cap
$13.53M
Return on Invested Capital (ROIC)
-28.72%
TTM Avg
-40.11%
3Y Avg
-38.90%
5Y Avg
-32.17%
Market Cap
$12.60M
Return on Invested Capital (ROIC)
-43.31%
TTM Avg
-42.56%
3Y Avg
-55.36%
5Y Avg
-44.03%
Market Cap
$12.50M
Return on Invested Capital (ROIC)
-784.16%
TTM Avg
-160.08%
3Y Avg
-118.03%
5Y Avg
-103.52%
Market Cap
$12.50M
Return on Invested Capital (ROIC)
-86.22%
TTM Avg
-227.24%
3Y Avg
-220.51%
5Y Avg
-220.51%
Market Cap
$12.51M
Return on Invested Capital (ROIC)
-203.50%
TTM Avg
-154.20%
3Y Avg
-205.70%
5Y Avg
-169.89%
Market Cap
$12.46M
Return on Invested Capital (ROIC)
-74.94%
TTM Avg
-273.26%
3Y Avg
-277.38%
5Y Avg
-186.51%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | $13.23M | -67.62% | -55.43% | -49.79% | -40.14% |
| IN8bio, Inc. (INAB)vs › | $13.11M | -91.74% | -119.31% | -112.64% | -88.90% |
| Passage Bio, Inc. (PASG)vs › | $13.08M | -889.92% | -97.42% | -82.73% | -70.79% |
| Optimi Health Corp. (OPTH)vs › | $13.53M | -28.72% | -40.11% | -38.90% | -32.17% |
| Cytosorbents Corporation (CTSO)vs › | $12.60M | -43.31% | -42.56% | -55.36% | -44.03% |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.50M | -784.16% | -160.08% | -118.03% | -103.52% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.50M | -86.22% | -227.24% | -220.51% | -220.51% |
| Dare Bioscience, Inc. (DARE)vs › | $12.51M | -203.50% | -154.20% | -205.70% | -169.89% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.46M | -74.94% | -273.26% | -277.38% | -186.51% |
| Lantern Pharma Inc. (LTRN)vs › | $12.40M | -358.04% | -62.86% | -6481.16% | -4328.67% |
ROIC
-67.6%
ROE
-69.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -67.62% |
| 2026-03-31 | -75.38% |
| 2025-12-31 | -36.35% |
| 2025-09-30 | -44.27% |
| 2025-06-30 | -53.54% |
| 2025-03-31 | -60.03% |
| 2024-12-31 | -56.25% |
| 2024-09-30 | -51.95% |
| 2024-06-30 | -44.19% |
| 2024-03-31 | -45.19% |
| 2023-12-31 | -42.28% |
| 2023-09-30 | -37.55% |
| 2023-06-30 | -32.65% |
| 2023-03-31 | -35.09% |
| 2022-12-31 | -29.21% |
| 2022-09-30 | -30.43% |
| 2022-06-30 | -26.73% |
| 2022-03-31 | -22.65% |
| 2021-12-31 | -18.92% |
| 2021-09-30 | -17.00% |
| 2021-06-30 | -15.70% |
| 2021-03-31 | -16.06% |
| 2020-12-31 | -67.07% |
| 2020-09-30 | -44.44% |
| 2020-06-30 | -49.27% |
| 2020-03-31 | -71.57% |
| 2019-12-31 | -75.14% |
| 2019-09-30 | -63.53% |
| 2019-06-30 | -71.97% |
| 2019-03-31 | -62.69% |
| 2018-12-31 | -59.21% |
| 2018-09-30 | -49.18% |
| 2018-06-30 | -57.46% |
| 2018-03-31 | -53.93% |
| 2017-12-31 | -40.12% |
| 2017-09-30 | -45.15% |
| 2017-06-30 | -64.61% |
| 2017-03-31 | -67.82% |
| 2016-12-31 | -53.97% |
| 2016-09-30 | -42.72% |
| 2016-06-30 | -27.33% |
| 2016-03-31 | -17.26% |
| 2014-03-31 | -53.16% |
| 2013-12-31 | -489.60% |
| 2013-09-30 | -29.14% |
